Replies to post #6045 on International Stem Cell Corp. (ISCO)

[Doctor_Hari_Seldon]

Yes, but that showed some weakness as of late. Hopefully not a sign of dwindling sales. I assumed a 1:150 RS, but it needed to be coupled with an equity offering/purchase that captured around $5/share so the could at least raise 5 million with significant dilution to us. Their burn rate has simply been too high. If they can make their stand alone products increase sales again and reduce other operational cost to make a small profit, they could then gain some real financial footing that would be supportive and not a negative. Even if they delayed trials, they need to get on some realistically sustainable budget with predictable health over a future time span of at least 24 months. If they do that, this will become a screaming buy! Until then, it could just go away, which would be extremely sad, not just for me and you, but for humanity in general.